BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27728977)

  • 1. Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer.
    Armstrong AJ; Li X; Tucker M; Li S; Mu XJ; Eng KW; Sboner A; Rubin M; Gerstein M
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):786-793. PubMed ID: 33568750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential elements of personalized medicine.
    Burke W; Brown Trinidad S; Press NA
    Urol Oncol; 2014 Feb; 32(2):193-7. PubMed ID: 24321254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era.
    Chen J; Zhang D; Yan W; Yang D; Shen B
    Biomed Res Int; 2013; 2013():901578. PubMed ID: 23957008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized prostate cancer care: from screening to treatment.
    Conran CA; Brendler CB; Xu J
    Asian J Androl; 2016; 18(4):505-8. PubMed ID: 27184548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
    Spahn M; Boxler S; Joniau S; Moschini M; Tombal B; Karnes RJ
    Curr Urol Rep; 2015 Oct; 16(10):70. PubMed ID: 26267226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular subtypes provide possibilities for precision medicine in a advanced prostate cancer].
    Wikström P; Bergh A; Josefsson A; Thysell E; Welén K
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38656744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access.
    Fenton SE; VanderWeeler DJ; Rebbeck TR; Chen DL
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e433138. PubMed ID: 38781539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine for prostate cancer: An international perspective.
    Hamid AA; Sweeney CJ; Hovens C; Corcoran N; Azad AA
    Urol Oncol; 2024 Apr; ():. PubMed ID: 38614920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of individualized prostate cancer and genomic biomarkers for the practicing urologist.
    McMahon GC; Brown GA; Mueller TJ
    Rev Urol; 2017; 19(2):97-105. PubMed ID: 28959146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress and perspectives on prostate cancer biomarkers.
    Hatakeyama S; Yoneyama T; Tobisawa Y; Ohyama C
    Int J Clin Oncol; 2017 Apr; 22(2):214-221. PubMed ID: 27730440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications.
    Terada N; Akamatsu S; Kobayashi T; Inoue T; Ogawa O; Antonarakis ES
    Ther Adv Med Oncol; 2017 Aug; 9(8):565-573. PubMed ID: 28794807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and biology of prostate cancer.
    Wang G; Zhao D; Spring DJ; DePinho RA
    Genes Dev; 2018 Sep; 32(17-18):1105-1140. PubMed ID: 30181359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in treating advanced prostate cancer.
    Gourdin T
    Curr Opin Oncol; 2020 May; 32(3):210-215. PubMed ID: 32209821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Surgical Management of Prostate Cancer.
    Sebesta EM; Anderson CB
    Semin Oncol; 2017 Oct; 44(5):347-357. PubMed ID: 29580436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMC4, a novel tumor prognostic marker and potential tumor therapeutic target.
    Zhao Z; Wang X; Ding Y; Cao X; Zhang X
    Front Oncol; 2023; 13():1117642. PubMed ID: 37007153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Genetic Complexity of Prostate Cancer.
    Compérat E; Wasinger G; Oszwald A; Kain R; Cancel-Tassin G; Cussenot O
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33255593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic outlier genes for enhanced prostate cancer treatment.
    Kim H; Skowronski J; Den RB
    Future Oncol; 2017 Feb; 13(3):249-261. PubMed ID: 27728977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer.
    Zhao SG; Evans JR; Kothari V; Sun G; Larm A; Mondine V; Schaeffer EM; Ross AE; Klein EA; Den RB; Dicker AP; Karnes RJ; Erho N; Nguyen PL; Davicioni E; Feng FY
    Clin Cancer Res; 2016 Apr; 22(7):1777-86. PubMed ID: 26631616
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.